Literature DB >> 30260509

Association between donor age and risk of graft failure after liver transplantation: an analysis of the Eurotransplant database.

Sebastian Pratschke1, Andreas Bender2, Florian Boesch1, Joachim Andrassy1, Marieke van Rosmalen3, Undine Samuel3, Xavier Rogiers4, Bruno Meiser5, Helmut Küchenhoff2, David Driesslein2, Jens Werner1, Markus Guba1, Martin K Angele1.   

Abstract

Grafts from elderly donors are increasingly used for liver transplantation. As of yet there is no published systematic data to guide the use of specific age cutoffs the effect of elderly donors on patient outcomes must be clarified. This study analyzed the Eurotransplant database (01/01/2000-31/07/2014; N = 26 294) out of whom 8341 liver transplantations were filtered to identify for this analysis. 2162 of the grafts came from donors >60 including 203 from octogenarians ≥80 years. Primary outcome was the risk of graft failure according to donor age using a confounder adjusted Cox-Regression model with frailty terms (or random effects). The proportion of elderly grafts increased during the study period [i.e., octogenarians 0.1% (n = 1) in 2000 to 3.4% (n = 45) in 2013]. Kaplan-Meier and Cox-analyses revealed a reduced survival and a higher risk for graft failure with increasing donor age. Although the age effect was allowed to vary non-linearly, a linear association hazard ratio (HR = 1.1 for a 10 year increase in donor age) was evident. The linearity of the association suggests that there is no particular age at which the effect increases more rapidly, providing no evidence for a cutoff age. In clinical practice, the combination of high donor age with HU-transplantations, hepatitis C, high MELD-scores and long cold ischemic time should be avoided.
© 2018 Steunstichting ESOT.

Entities:  

Keywords:  clinical liver transplantation; cox regression model; cutoff age; donor age; frailty terms; graft failure

Mesh:

Year:  2018        PMID: 30260509     DOI: 10.1111/tri.13357

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  How Old Is Old? An Age-Stratified Analysis of Elderly Liver Donors above 65.

Authors:  Philipp Houben; Eike Bormann; Felicia Kneifel; Shadi Katou; Mehmet Haluk Morgül; Thomas Vogel; Ralf Bahde; Sonia Radünz; Andreas Pascher; Hartmut Schmidt; Jens Gunther Brockmann; Felix Becker
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

2.  [High donor age for liver transplantation : Tackling organ scarcity in Germany].

Authors:  S Moosburner; P V Ritschl; L Wiering; J M G V Gassner; R Öllinger; J Pratschke; I M Sauer; N Raschzok
Journal:  Chirurg       Date:  2019-09       Impact factor: 0.955

3.  The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications-Who Is at Risk? A Collaborative Transplant Study Report.

Authors:  Vladimir J Lozanovski; Bernd Döhler; Karl Heinz Weiss; Arianeb Mehrabi; Caner Süsal
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

4.  Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma.

Authors:  Vladimir J Lozanovski; Larissa T B Kerr; Elias Khajeh; Omid Ghamarnejad; Jan Pfeiffenberger; Katrin Hoffmann; De-Hua Chang; Markus Mieth; Thomas Longerich; Oliver Strobel; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

Review 5.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

6.  Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis.

Authors:  Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok
Journal:  Hepatol Commun       Date:  2020-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.